News Ticker

Bayer Bets on ‘Silver Bullet’ Defense in Roundup Litigation; Experts See Hurdles

By Tina Bellon | 16 May 2019

REUTERS — Bayer AG plans to argue that a $2 billion jury award and thousands of U.S. lawsuits claiming its glyphosate-based weed killer Roundup causes cancer should be tossed because a U.S. regulatory agency said the herbicide is not a public health risk.

Some legal experts believe Bayer will have a tough time convincing appellate courts to throw out verdicts and lawsuits on those grounds. Bayer has a better shot if a business-friendly U.S. Supreme Court takes up the case, experts said. But that could take years.

Bayer has come under intensifying pressure after a third consecutive U.S. jury on Monday found Roundup to be carcinogenic, awarding more than $2 billion to a couple who used the chemical on their property — the largest verdict in the glyphosate litigation to date.

Bayer, which inherited the Roundup litigation with its $63 billion acquisition of Monsanto last year, faces lawsuits by more than 13,400 plaintiffs nationwide, alleging the product causes cancer. […]

Be the first to comment

Post a Comment

%d bloggers like this:
Secured By miniOrange